Agents that act luminally to treat diarrhoea and constipation

Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation

(2012) W. D. Chey et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Randomised clinical trial: efficacy of Lactobacillus paracasei-enriched artichokes in the treatment of patients with functional constipation - a double-blind, controlled, crossover study

(2012) G. Riezzo et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Rates of Self-Reported Urinary, Gastrointestinal, and Pain Comorbidities in Women With Vulvar Lichen Sclerosus

(2012) Mitchell B. Berger et al.   Journal of Lower Genital Tract Disease

Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation

(2011) A. Attaluri et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review: the effects of fibre in the management of chronic idiopathic constipation

(2011) N. C. Suares et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The Efficacy and Safety of Rifaximin for the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis

(2011) Stacy B Menees et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

A Randomized Placebo-Controlled Phase IIb Trial of A3309, A Bile Acid Transporter Inhibitor, for Chronic Idiopathic Constipation

(2011) William D Chey et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The laxative effect of bisacodyl is attributable to decreased aquaporin-3 expression in the colon induced by increased PGE2 secretion from macrophages

(2011) Nobutomo Ikarashi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Oral Bisacodyl Is Effective and Well-Tolerated in Patients With Chronic Constipation

(2011) Michael A. Kamm et al.   Clinical Gastroenterology and Hepatology

Pharmacology of the New Treatments for Lower Gastrointestinal Motility Disorders and Irritable Bowel Syndrome

(2011) M Camilleri   CLINICAL PHARMACOLOGY & THERAPEUTICS

Racecadotril for childhood gastroenteritis: an individual patient data meta-analysis

(2011) Philippe Lehert et al.   DIGESTIVE AND LIVER DISEASE

A Palpable Mass in a Young Man With Chronic Lower Abdominal Pain

(2011) Ching-Wei Chang et al.   GASTROENTEROLOGY

Pharmacologic and Complementary and Alternative Medicine Therapies for Irritable Bowel Syndrome

(2011) William D. Chey et al.   Gut and Liver

World Gastroenterology Organisation Global Guideline

(2011) &NA;   JOURNAL OF CLINICAL GASTROENTEROLOGY

Efficacy and safety of oral lubiprostone in constipated patients with or without irritable bowel syndrome: a randomized, placebo-controlled and dose-finding study

(2011) S. Fukudo et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Two Randomized Trials of Linaclotide for Chronic Constipation

(2011) Anthony J. Lembo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

(2011) Mark Pimentel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Targeting bile acids in the treatment of constipation

(2011) Monthira Maneerattanaporn et al.   Expert Review of Gastroenterology & Hepatology

Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation

(2010) J. F. JOHANSON et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Efficacy of a Chinese Herbal Proprietary Medicine (Hemp Seed Pill) for Functional Constipation

(2010) Chung-Wah Cheng et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Multicenter, 4-Week, Double-Blind, Randomized, Placebo-Controlled Trial of Sodium Picosulfate in Patients With Chronic Constipation

(2010) Stefan Mueller-Lissner et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: A retrospective chart review and patient questionnaire

(2010) Linda Wedlake et al.   CLINICAL THERAPEUTICS

Chenodeoxycholate in Females With Irritable Bowel Syndrome-Constipation: A Pharmacodynamic and Pharmacogenetic Analysis

(2010) Archana S. Rao et al.   GASTROENTEROLOGY

Linaclotide Improves Abdominal Pain and Bowel Habits in a Phase IIb Study of Patients With Irritable Bowel Syndrome With Constipation

(2010) Jeffrey M. Johnston et al.   GASTROENTEROLOGY

Efficacy of Linaclotide for Patients With Chronic Constipation

(2010) Anthony J. Lembo et al.   GASTROENTEROLOGY

Pharmacologic Management of Chronic Constipation

(2010) Siddharth Singh et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract

(2010) Alexander P. Bryant et al.   LIFE SCIENCES

Alosetron for severe diarrhea-predominant irritable bowel syndrome: safety and efficacy in perspective

(2010) James H Lewis   Expert Review of Gastroenterology & Hepatology

Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome

(2009) L. WEDLAKE et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Efficacy of 5-HT3 Antagonists and 5-HT4 Agonists in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis

(2009) Alexander C Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The Utility of Probiotics in the Treatment of Irritable Bowel Syndrome: A Systematic Review

(2009) Darren M Brenner et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Recent advances in the understanding of bile acid malabsorption

(2009) S. Pattni et al.   BRITISH MEDICAL BULLETIN

Effects of Chenodeoxycholate and a Bile Acid Sequestrant, Colesevelam, on Intestinal Transit and Bowel Function

(2009) Suwebatu T. Odunsi–Shiyanbade et al.   Clinical Gastroenterology and Hepatology

Efficacy and Safety of Lubiprostone in Patients with Chronic Constipation

(2009) Charles F. Barish et al.   DIGESTIVE DISEASES AND SCIENCES

Burden of Digestive Diseases in the United States Part II: Lower Gastrointestinal Diseases

(2009) James E. Everhart et al.   GASTROENTEROLOGY

Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy

(2009) Guang-hui Li et al.   MEDICAL ONCOLOGY

Crofelemer, an Antisecretory Antidiarrheal Proanthocyanidin Oligomer Extracted from Croton lechleri, Targets Two Distinct Intestinal Chloride Channels

(2009) L. Tradtrantip et al.   MOLECULAR PHARMACOLOGY

Clinical trial: the effects of a fermented milk product containingBifidobacterium lactisDN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation

(2008) A. AGRAWAL et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome - results of two randomized, placebo-controlled studies

(2008) D. A. DROSSMAN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Evaluation of Crofelemer in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome Patients

(2008) Allen W. Mangel et al.   DIGESTION

European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases Evidence-based Guidelines for the Management of Acute Gastroenteritis in Children in Europe

(2008) &NA;   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

“Melanosis” in the small and large intestine

(2008) Hugh James Freeman   WORLD JOURNAL OF GASTROENTEROLOGY

Lubiprostone for chronic idiopathic constipation and irritable bowel syndrome with constipation

(2008) Richard Saad et al.   Expert Review of Gastroenterology & Hepatology

The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing

(2008) Les Dethlefsen et al.   PLOS BIOLOGY

Multicenter, 4-Week, Double-Blind, Randomized, Placebo-Controlled Trial of Lubiprostone, a Locally-Acting Type-2 Chloride Channel Activator, in Patients With Chronic Constipation

(2007) John F Johanson et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY